From Prompt to Phase III: Biomarker Discovery for Bispecific Antibodies in DLBCL
K-Dense Web integrated 6 databases, ranked 6 candidate biomarkers, and produced Phase III trial design recommendations for CD20xCD3 bispecifics in DLBCL.
8 min read
Topic
Biomarker Discovery
1 K-Dense article on Biomarker Discovery — research automation, benchmarks, and case studies from the K-Dense team.